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Early identiﬁ cation and treatment of pneumonia: 
a call to action 
On the seventh World Pneumonia Day on Nov 12, 2015, 
we call for action to improve the early identiﬁ cation and 
treatment of childhood pneumonia at community and 
outpatient level to reduce deaths. 
Of the estimated 5·9 million deaths in children 
younger than 5 years in 2015, pneumonia was one of 
the leading killers, causing 16% of deaths.1 Most of these 
deaths are readily preventable or treatable with proven, 
cost-eﬀ ective interventions.2 Yet treatment is received 
by half of sick children, and only 54% with symptoms 
of pneumonia are taken outside the home for care.1 
Therefore, action must be taken immediately to save 
children’s lives by expanding services that allow early 
identiﬁ cation of symptoms and appropriate treatment.
The case–fatality rate in untreated children with 
pneumonia is high, sometimes reaching 20%,3 and 
death can occur as early as 3 days after illness onset.4 
Early identiﬁ cation of pneumonia and appropriate 
treatment saves lives. By initiating antibiotic therapy 
soon after onset of symptoms such as fast breathing 
in a child with cough, the progression of a pneumonia 
infection is blunted.5 In the absence of early intervention, 
pneumonia progresses to a state where even 
intravenous antibiotics have limited impact, leading 
to the high hospital case–fatality rates for children.6 Of 
an estimated 15 million hospital admissions for severe 
and very severe pneumonia globally in 2010, 0·3 million 
died, approximately 19% in a hospital.7 Delayed care-
seeking behaviour or poor access to hospital care, or 
both, explained the high number of severe pneumonia 
cases observed in hospitals. 
Clinical trials show that children with fast-breathing 
pneumonia can be eﬀ ectively treated with oral 
antibiotics.8 As a result, many low-income and 
middle-income countries have now adopted policies 
for community case management of sick children in 
underserved communities, as recommended by WHO 
and UNICEF.9 Evidence shows that when children 
are treated in accordance with these standard case 
management guidelines at health facilities or by 
community health workers (CHWs), children are treated 
promptly,10 antibiotics are used more appropriately,10,11 
and mortality is reduced.8 Recently, WHO released new 
guide lines for treatment of lower chest indrawing 
pneumonia with oral amoxicillin on an outpatient 
basis.12 The rationale for introducing the new guidelines 
was not only because they are likely to reduce societal 
costs (due to less hospitalisation), but because they 
deliver better outcomes. 
The WHO pneumonia management guideline is 
presumptive, based on identiﬁ cation of clinical signs 
in children with cough or diﬃ  cult breathing and on 
treatment with antibiotics. Some argue that CHWs have 
insuﬃ  cient capacity to correctly manage pneumonia13 
and that the evidence of eﬃ  cacy of antibiotic treatment 
for fast-breathing pneumonia is questionable, especially 
when wheeze is present.14 However, CHWs who have 
appropriate training, adequate supervision, and 
availability of drugs and necessary supplies have shown 
ability to provide quality care for pneumonia.15 Although 
wheeze is more common in viral infections and often 
responds well to broncho dilators,14 a placebo-controlled 
double blind trial showed higher clinical treatment 
failure in children with fast-breathing pneumonia and 
wheeze who received placebo compared to antibiotic.16 
Mixed viral and bacterial infections are common,17 
yet eﬀ orts to identify other clinical features to better 
diagnose bacterial pneumonia have not succeeded.18 
Since it is still impossible to clinically diﬀ erentiate viral 
from bacterial pneumonia, prompt treatment of clinical 
pneumonia with antibiotics will remain a priority for the 
foreseeable future. 
Antibiotics can eﬀ ectively treat pneumonia, but 
hypoxaemia is a good marker of disease severity and is 
often associated with adverse outcome.19 It is diﬃ  cult 
to clinically identify hypoxaemia but the use of pulse 
oximetry and management of hypoxaemia with oxygen 
is associated with improved quality of care and reduced 
mortality. WHO recommends use of pulse oximetry 
to identify hypoxaemia and its management with 
oxygen.12 Pulse oximetry is a reliable and non-invasive 
method for identifying hypo xaemia in children, yet 
these devices are rarely available outside the higher-
level facilities in resource-constrained countries.
To reduce childhood deaths, early identiﬁ cation and 
prompt treatment of pneumonia is essential. Standard 
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case management of childhood pneumonia (including 
community case management) is an eﬀ ective strategy 
to reduce the burden on hospital services, and improve 
equity.7 Identiﬁ cation and management of hypoxaemia 
are essential along with antibiotics to reduce severe 
pneumonia mortality. This scale-up will need permissive 
policies allowing community health workers to detect 
and treat pneumonia with antibiotics, research and 
development to improve pneumonia diagnosis, and 
ﬁ nancial support for introduction and maintenance of 
pulse oximeters and oxygen therapy in health centres 
and hospitals.
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